Our History

Virogin Biotech was founded in 2015, with a vision to be a global, best-in-class oncolytic virus company that creates impactful drugs for patients of highest medical need.
April 01, 2015
Virogin Biotech Canada established.
April 30, 2015
Virogin Biotech Hong Kong established.
August 10, 2015
Seed run financing finished.
August 14, 2015
Shenzhen Virogin Biotech established.
February 16, 2016
A1 run financing finished.
January 24, 2017
A2 run financing finished.
February 16, 2018
B1 run financing finished.
April 17, 2018
Shanghai Virogin Biotech established.
July 10, 2018
Virogin Biotech Australia established.
November 29, 2018
B2 run financing finished.
May 14, 2019
CNBG-Virogin (Joint Venture) established.
March 9, 2020
Furong Virogin established.
September 30, 2020
C run financing finished.
May 12, 2021
D1 run financing finished.
May 17, 2021
Hangzhou Virogin established.
December 9, 2021
Virogin Biotech Singapore established.
December 15, 2021
D2 run financing finished.
February 7, 2022
Virogin USA established.